Wang C - Search Results

1

Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer.

Zou J, Han Z, Zhou L, Cai C, Luo H, Huang Y, Liang Y, He H, Jiang F, Wang C, Zhong W. Zou J, et al. Among authors: wang c. Med Oncol. 2015 Jan;32(1):373. doi: 10.1007/s12032-014-0373-1. Epub 2014 Dec 3. Med Oncol. 2015. PMID: 25465060

2

Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer.

Zeng YR, Han ZD, Wang C, Cai C, Huang YQ, Luo HW, Liu ZZ, Zhuo YJ, Dai QS, Zhao HB, Liang YX, Zhong WD. Zeng YR, et al. Among authors: wang c. BMC Urol. 2015 Aug 29;15:90. doi: 10.1186/s12894-015-0085-7. BMC Urol. 2015. PMID: 26320076 Free PMC article.

3

Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer.

Fu X, Chen G, Cai ZD, Wang C, Liu ZZ, Lin ZY, Wu YD, Liang YX, Han ZD, Liu JC, Zhong WD. Fu X, et al. Among authors: wang c. Onco Targets Ther. 2016 Apr 15;9:2211-20. doi: 10.2147/OTT.S101994. eCollection 2016. Onco Targets Ther. 2016. PMID: 27143916 Free PMC article.

4

Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer.

Liu J, Chen G, Liu Z, Liu S, Cai Z, You P, Ke Y, Lai L, Huang Y, Gao H, Zhao L, Pelicano H, Huang P, McKeehan WL, Wu CL, Wang C, Zhong W, Wang F. Liu J, et al. Among authors: wang f, wang c. Cancer Res. 2018 Aug 15;78(16):4459-4470. doi: 10.1158/0008-5472.CAN-17-3226. Epub 2018 Jun 11. Cancer Res. 2018. PMID: 29891507 Free PMC article.

5

Overexpression of TPX2 is associated with progression and prognosis of prostate cancer.

Zou J, Huang RY, Jiang FN, Chen DX, Wang C, Han ZD, Liang YX, Zhong WD. Zou J, et al. Among authors: wang c. Oncol Lett. 2018 Sep;16(3):2823-2832. doi: 10.3892/ol.2018.9016. Epub 2018 Jun 25. Oncol Lett. 2018. PMID: 30127868 Free PMC article.

6

ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.

Chen G, Cai ZD, Lin ZY, Wang C, Liang YX, Han ZD, He HC, Mo RJ, Lu JM, Pan B, Wu CL, Wang F, Zhong WD. Chen G, et al. Among authors: wang f, wang c. Mol Carcinog. 2020 Aug;59(8):897-907. doi: 10.1002/mc.23201. Epub 2020 Apr 22. Mol Carcinog. 2020. PMID: 32319143

7

P7 peptides targeting bFGF sensitize colorectal cancer cells to CPT-11.

Luo W, Yu Y, Wang R, He D, Wang C, Zeng X, Chen X, Tan X, Huang T, Wu X. Luo W, et al. Among authors: wang c, wang r. Int J Mol Med. 2014 Jan;33(1):194-200. doi: 10.3892/ijmm.2013.1547. Epub 2013 Nov 4. Int J Mol Med. 2014. PMID: 24190390

8

A novel bFGF antagonist peptide inhibits breast cancer cell growth.

Li Q, Gao S, Yu Y, Wang W, Chen X, Wang R, Li T, Wang C, Li X, Wu X. Li Q, et al. Among authors: wang w, wang c, wang r. Mol Med Rep. 2012 Jul;6(1):210-4. doi: 10.3892/mmr.2012.882. Epub 2012 Apr 20. Mol Med Rep. 2012. PMID: 22576745

9

Mechanism of antitumor effect of a novel bFGF binding peptide on human colon cancer cells.

Wang C, Lin S, Nie Y, Jia X, Wang J, Xiao J, Wu J, Li X, Wu X. Wang C, et al. Among authors: wang j. Cancer Sci. 2010 May;101(5):1212-8. doi: 10.1111/j.1349-7006.2010.01501.x. Epub 2010 Jan 19. Cancer Sci. 2010. PMID: 20331620 Free PMC article.

10

RNA Interference against ATP as a Gene Therapy Approach for Prostate Cancer.

Chen S, Ma J, Xiao Y, Zhou D, He P, Chen Y, Zheng X, Lin H, Qiu F, Yuan Y, Zhong J, Li X, Pan X, Fang Z, Wang C. Chen S, et al. Among authors: wang c. Mol Pharm. 2023 Oct 2;20(10):5214-5225. doi: 10.1021/acs.molpharmaceut.3c00587. Epub 2023 Sep 21. Mol Pharm. 2023. PMID: 37733628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109,145 results

Search Page

Filters